RS1926447 Unknown gene
Upload your DNA to see your genotype for this variant.
What This Variant Does
"Thrombin-activatable fibrinolysis inhibitor Thr325Ile polymorphism and plasma level in breast cancer: A pilot study"
GWAS Studies (20)
| Trait | Risk Allele | OR / Beta | P-value | Study |
|---|---|---|---|---|
| Serum levels of protein ALPI | A | OR: 0.52 | 1E-155 | PubMed |
| MAP kinase-activated protein kinase 3 levels | A | OR: 1.1 | 2E-145 | PubMed |
| Serum levels of protein TOR1AIP1 | A | OR: 0.44 | 3E-96 | PubMed |
| Serum levels of protein RAET1E | A | OR: 0.41 | 3E-92 | PubMed |
| MAP kinase-activated protein kinase 3 levels | — | OR: 0.66 | 3E-88 | PubMed |
| Serum levels of protein CRLF2 | A | OR: 0.36 | 6E-60 | PubMed |
| NKG2D ligand 4 levels (RAET1E.7800.85.3) | G | OR: 0.43 | 5E-58 | PubMed |
| CBPB2 protein level (protein group normalized intensity) | A | OR: 0.51 | 3E-45 | PubMed |
| Succinate-semialdehyde dehydrogenase, mitochondrial level in Chronic kidney disease with hypertension and no diabetes (17792_158) | G | OR: 1.06 | 3E-41 | PubMed |
| Serine/threonine-protein kinase Chk1 protein levels (SomaScan ID:13634-209) | G | OR: 1.13 | 3E-32 | PubMed |
| Trimeric intracellular cation channel type B protein levels (SomaScan ID:16593-3) | G | OR: 1.11 | 1E-30 | PubMed |
| Serum levels of protein TOM1L1 | A | OR: 0.23 | 6E-30 | PubMed |
| MAP kinase-activated protein kinase 3 level in Chronic kidney disease with hypertension and no diabetes (3822_54) | G | OR: 0.94 | 7E-30 | PubMed |
| Pirin level in Chronic kidney disease with hypertension and no diabetes (13634_209) | G | OR: 0.89 | 2E-26 | PubMed |
| Protein quantitative trait loci | — | — | 3E-24 | PubMed |
| CD164 sialomucin-like 2 protein protein levels (SomaScan ID:19145-4) | G | OR: 0.89 | 8E-18 | PubMed |
| UPF0488 protein C8orf33 levels (C8orf33.9613.16.3) | G | OR: 0.22 | 3E-16 | PubMed |
| Serum levels of protein MIF | A | OR: 0.15 | 2E-13 | PubMed |
| Serum levels of protein IFNA10 | A | OR: 0.16 | 8E-13 | PubMed |
| Macrophage Migration Inhibitory Factor levels | A | OR: 0.35 | 1E-12 | PubMed |